Zhang, ShenghongShenghongZhangChen, BailiBailiChenWang, BangmaoBangmaoWangChen, HongHongChenLi, YanYanLiCao, QianQianCaoZhong, JieJieZhongMING-JIUM SHIEHRan, ZhihuaZhihuaRanTang, TongyuTongyuTangYang, MingMingYangXu, BeibeiBeibeiXuWang, QiangQiangWangLiu, YunjieYunjieLiuMa, LijiaLijiaMaWang, XiaolinXiaolinWangZhang, NanNanZhangZhang, SuSuZhangGuo, WenyuWenyuGuoHuang, LiangLiangHuangSchreiber, StefanStefanSchreiberChen, MinhuMinhuChen2024-01-102024-01-102023-03-0700987484https://scholars.lib.ntu.edu.tw/handle/123456789/638355Olamkicept, a soluble gp130-Fc-fusion-protein, selectively inhibits interleukin 6 (IL-6) trans-signaling by binding the soluble IL-6 receptor/IL-6 complex. It has anti-inflammatory activities in inflammatory murine models without immune suppression.en[SDGs]SDG3Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis: A Randomized Clinical Trialjournal article10.1001/jama.2023.1084368810322-s2.0-85149593728https://api.elsevier.com/content/abstract/scopus_id/85149593728